The goal of the COE program is to establish a global network of centers with expertise in distinct research areas to expand the utility of the DSP platform. Centers of Excellence will be the first to have access to DSP and an emerging menu of content. Each COE will establish a consortium of users and conduct technology workshops to increase awareness of DSP and generate impactful data demonstrating the utility of highly multiplexed spatial analysis.
“We are excited to lead the DSP Center of Excellence to develop clinical research applications and identify novel biomarkers on this platform,” said Dr.
“Establishing Centers of Excellence will enhance the awareness and establish the utility of the Digital Spatial Profiling platform for clinical research and biomarker development,” said
NanoString Technologies provides life science tools for translational research and molecular diagnostic products. The company's nCounter® Analysis System has been employed in life sciences research since it was first introduced in 2008 and has been cited in more than 2,000 peer-reviewed publications. The nCounter Analysis System offers a cost-effective way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision, facilitating a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. The company's technology is also being used in diagnostics. The Prosigna® Breast Cancer Prognostic Gene Signature Assay together with the nCounter Dx Analysis System is FDA 510(k) cleared for use as a prognostic indicator for distant recurrence of breast cancer. In addition, the company collaborates with biopharmaceutical companies in the development of companion diagnostic tests for various cancer therapies, helping to realize the promise of precision oncology.
For more information, please visit www.nanostring.com.
Vice President, Investor Relations & Corporate Communications
Source: NanoString Technologies, Inc.